Biotech

All Articles

Zephyrm looks for Hong Kong IPO to fund phase 3 tissue therapy tests

.Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO to bankr...

Frazier Lifestyle Sciences collects $630M for little, mid-cap biotechs

.Frazier Lifespan Sciences has sourced an even further $630 thousand for its own fund concentrated o...

GigaGen gathers approximately $135M BARDA bucks to hammer botox

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its t...

GPCR firm Septerna apply for IPO on stamina of preclinical information

.Septerna will learn just how a biotech without "any sort of relevant professional data" fares in th...

Kurma finalizes first $154M payload for largest biotech fund as yet

.European VC agency Kurma Allies has actually revealed its own most up-to-date biotech fund, along w...

Prothena promotes one exec while an additional leaves-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of considerable management hirings, firings ...

Editas exploit Tip Cas9 licensing civil rights for $57M

.Versus the backdrop of a Cas9 patent battle that rejects to die, Editas Medicine is cashing in a pi...

Ultragenyx fine-tunes gene treatment application to dial up efficacy

.A minority of people taking Ultragenyx Pharmaceutical's Wilson ailment genetics treatment UX701 hav...

Biopharma unemployment rate maintains in Q3: Tough Biotech analysis

.As summertime heat relies on cool winds, really hopes that this year would certainly deliver widesp...

J &amp J falls stage 2 dengue candidate in newest shift from vaccines

.Johnson &amp Johnson's deprioritization of its transmittable health condition pipeline has asserted...